Ictero Medical

Industry
Medical Devices
Founded Year
2018
Headquarters
Houston, Texas
Employee Count
25

Key People

Assessment

Team
Aspect: First-time 10+ yrs
Summary: The leadership team comprises first-time entrepreneurs with over a decade of experience in the medical device industry.

The leadership's background in medical devices provides a solid foundation for navigating product development and market entry challenges.

Clinical Need
Aspect: Very Strong
Summary: There is a significant unmet need for non-surgical gallstone treatments, especially for high-risk patients.

Traditional cholecystectomy poses risks for certain patient groups; a minimally invasive alternative like CholeSafe System could revolutionize treatment protocols.

Competition
Aspect: First mover
Summary: Ictero Medical appears to be pioneering in the gallbladder ablation space with limited direct competition.

The lack of established competitors allows Ictero Medical to capture market share and establish brand recognition early.

Technical Challenge
Aspect: Moderate
Summary: Developing a safe and effective ablation device for gallbladder treatment presents moderate technical challenges.

Ensuring precise ablation without damaging surrounding tissues requires careful engineering and extensive testing.

Patent
Aspect: Applied
Summary: The company has applied for patents related to its CholeSafe System.

While patent applications are in process, granted patents would provide stronger protection against competitors.

Financing
Aspect: Medium
Summary: Ictero Medical has secured moderate funding to support its development and clinical testing phases.

While current funding supports initial phases, scaling production and marketing efforts will necessitate further investment.

Regulatory
Aspect: Running FIH
Summary: The company is conducting First-In-Human trials for the CholeSafe System.

Successful completion of clinical trials is critical for obtaining FDA approval and subsequent market entry.

Opportunity Rollup

Odds of Success
3.7
Peak Market Share
5.2
Segment CAGR
6.89%
Market Segment
Ablation Devices
Market Sub Segment
Gallbladder Ablation Devices
Year Post Launch Market Penetration (%)
1 0.26
2 0.78
3 1.82
4 3.64
5 5.20

Key Takeaway

Ictero Medical's innovative approach addresses a significant clinical need, positioning it well in a growing market, though challenges in funding and regulatory approval remain.